JonesTrading Initiates Coverage On Purple Biotech with Buy Rating, Announces Price Target of $8
Portfolio Pulse from richadhand@benzinga.com
JonesTrading analyst Catherine Novack has initiated coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and a price target of $8.
July 21, 2023 | 9:13 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Purple Biotech has been initiated with a Buy rating by JonesTrading, with a price target of $8.
The initiation of coverage by JonesTrading with a Buy rating and a price target of $8 indicates a positive outlook for Purple Biotech. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100